Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study

OBJECTIVE: To assess the safety, tolerability, and feasibility of adult allogeneic bone marrow–derived mesenchymal precursor cells (MPCs) in type 2 diabetes inadequately controlled with metformin either alone or with one additional oral antidiabetic agent. RESEARCH DESIGN AND METHODS: The study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Skyler, Jay S., Fonseca, Vivian A., Segal, Karen R., Rosenstock, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Emerging Technologies and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542273/
https://www.ncbi.nlm.nih.gov/pubmed/26153271
http://dx.doi.org/10.2337/dc14-2830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542273/
https://www.ncbi.nlm.nih.gov/pubmed/26153271
http://dx.doi.org/10.2337/dc14-2830

Ejemplares similares